Eight novel variants in the SLC34A2 gene in pulmonary alveolar microlithiasis

Åsa Lina M Jönsson1, Elisabeth Bendstrup2, Susie Mogensen3

  • 1Dept of Biomedicine, Aarhus University, Aarhus, Denmark aasajoen@rm.dk.

Abstract

Insights

Genetic variants in the SLC34A2 gene cause Pulmonary Alveolar Microlithiasis (PAM). This study identified eight novel SLC34A2 variants and found a correlation between disease severity and variant severity in PAM patients.

Area of Science:

  • Genetics
  • Pulmonology
  • Molecular Biology

Background:

  • Pulmonary Alveolar Microlithiasis (PAM) is a rare genetic disorder.
  • It is caused by variants in the SLC34A2 gene, encoding the NaPi-2b phosphate transporter.
  • The full spectrum of SLC34A2 variants and their link to disease severity were previously unknown.

Purpose of the Study:

  • To investigate the variant spectrum of the SLC34A2 gene in PAM patients.
  • To explore the genotype-phenotype correlation in Pulmonary Alveolar Microlithiasis.
  • To identify novel genetic variants associated with PAM.

Main Methods:

  • DNA sequencing of the SLC34A2 gene in 14 PAM patients and four relatives.
  • Analysis of coding regions for genetic variants.
  • Clinical data collection and creation of a variant severity score.

Main Results:

  • Eight novel allelic variants of SLC34A2 were identified in 14 PAM patients.
  • Four nonsense, three missense, and one splice site variant were discovered.
  • A correlation between disease severity and the severity of SLC34A2 variants was observed.

Conclusions:

  • The study confirms the significant role of SLC34A2 in Pulmonary Alveolar Microlithiasis.
  • The identified variants expand the known spectrum of SLC34A2 mutations in PAM.
  • A genotype-phenotype correlation suggests variant severity influences disease manifestation, warranting further investigation.

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.8K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
670
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
18.5K
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
43.1K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.0K
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
154.8K